NASDAQ: CRME TSX: COM. Cardiome Pharma Corp. today announced that it has earned a US$30 million milestone payment from its collaboration with Merck, through an affiliate.
Oncolytics Biotech Inc. announced today that the Gynecologic Oncology Group intends to conduct a randomized Phase II trial of weekly paclitaxel versus weekly paclitaxel with REOLYSIN in patients with persistent or recurrent, ovarian, fallopian tube or primary peritoneal cancer.
Fibromyalgia treatment protocol includes discovery of the root cause of fibromyalgia pain, and how to correct and eliminate the pain. It's been the million dollar question plaguing sufferers for centuries, and has confused doctors to the present day: What in the world is fibromyalgia? "Teamed up with Western medicine, pharmaceutical companies offer temporary fixes for each symptom that arises.
Addex Pharmaceuticals / Addex drug-candidate effective in Alzheimer's disease model processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. Geneva, Switzerland, 2 September 2010 - Allosteric modulation company Addex Pharmaceuticals Ltd (SIX: ADXN) announced today that it has observed efficacy in a model of Alzheimer's disease using a ...
CONCORD, Calif.--(BUSINESS WIRE)--Sep 2, 2010 - Cerus Corporation announced today the successful outcome of a multi-year trial of INTERCEPT-treated platelet components conducted at the Swiss Red Cross Blood Center in Basel, Switzerland.
NEW YORK -- Shares of some top medical devices companies are mixed at 1 p.m.: Abbott Labs rose $.06 or .1 percent, to $50.33. Allergan unchanged at $63.28. Bard fell $.09 or .1 percent, to $77.88. Baxter rose $.30 or .7 percent, to $43.77. Boston Scientific rose $.11 or 2.1 percent, to $5.24. Hospira rose $.72 or 1.4 percent, to $53.58. Johnson & Johnson rose $.08 or .1 percent, to $58.37. Medt...
